SRCSGT | 65 | The Pacific Region-Tri Service Regional Business Office, comprised of 17 Medical Treatment Facilities announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Blood Pressure Cuffs, Reusable.

FBO DAILY ISSUE OF SEPTEMBER 12, 2008 FBO #2482
SOURCES SOUGHT

65 -- The Pacific Region-Tri Service Regional Business Office, comprised of 17 Medical Treatment Facilities announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Blood Pressure Cuffs, Reusable.

Notice Date: 9/10/2008
Notice Type: Sources Sought
NAICS: 423450 — Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Contracting Office: Department of the Army, U.S. Army Medical Command, Pacific Regional Contr Ofc TAMC, Pacific Regional Contr Ofc TAMC, ATTN: MCAA PC BLDG 160, 160 Krukowski Road, Honolulu, HI 96859-5000
ZIP Code: 96859-5000
Solicitation Number: W81K02-08-T-3021
Response Due: 10/1/2008
Archive Date: 11/30/2008
Point of Contact: Susan Hwang, 808-433-3686<br />
Small Business Set-Aside: N/A
Description: The Pacific Region-Tri Service Regional Business Office (TRBO) Region 12, a military integrated delivery network, comprised of 17 Army, Navy, Air Force, and Marine Corps Medical Treatment Facilities (MTFs) in Hawaii, Guam, Okinawa, Japan, and Korea announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Blood Pressure Cuffs, Reusable. The primary objective of this program is to standardize the quality of care across the region based on a best value determination that represents the clinically preferred product or source(s) at the best possible price. It is also intended that standardized products be obtained through the Department of Defense Prime Vendor Program The major facilities in the region include Tripler Army Medical Center, U.S. Naval Hospital Okinawa, U.S. Naval Hospital Guam, U.S. Naval Hospital Yokosuka, and 374th Medical Group, Yokota AB, Japan. This standardization action is part of the Medical/Surgical Prime Vendor program executed by the Defense Supply Center Philadelphia (DSCP), Directorate of Medical Materiel. In order to participate, your company must have a Distribution and Pricing Agreement (DAPA) and a separate commercial agreement with the Prime Vendors for the program. This is pursuant to the DAPA clause by which DAPA holders agree to the standardization process and to allow Prime Vendors to distribute their products. This RFRIAQ is a supplement to the Prime Vendor Program and is not a contract. For additional information regarding DSCPs Prime vendor program please access their web site at https://dmmonline.dscp.dla.mil The resulting Regional Incentive Agreement (RIA) will be for a base period of two years (24 months) from date of selection with three 12-month option periods. Anticipated selection date is May 2009. The evaluation will be based on technical, clinical, and pricing factors. The Technical/Company and Clinical/Performance evaluation factors, when combined, are considered significantly more important than cost or price. As the technical and clinical evaluation results become more equal, price will become more important. The selection will be determined utilizing best value/ trade-off criteria. The selection of a single vendor is anticipated. However, if no single vendor can meet the total requirement of the Region, the Government reserves the right to make two or more selections for RIAs. In this event, selection would be based on a combination of MTF preference and product availability. Point of Contact: Mary Summers, TRBO Team Leader 808-433-3686, mary.summers1@us.army.mil Cheryl Janus, RN, TRBO Clinical Analyst 808-433-7985, cheryl.janus@amedd.army.mil B. Products & Performance Required. The Pacific Region is seeking product line items in the category of Blood Pressure Cuffs, Reusable, which at a minimum includes the high volume lines below. Within this region, this product line has an estimated annual dollar requirement of $29,465. This forecast is based on historical prime vendor sales during a recent 12-month period. The top high volume usage lines for this project include: #DS45-11, CUFF BP 1 PC GRAY ADULT, 160 Del Qty, $6,337.60 # 002698, CUFF BP DURA-CUF ASSORTMENT PACK, 32 Del Qty, $2,559.99 # 5082-86-3HP, CUFF BLOOD PRESSURE ADULT, 27 Del Qty, $2,144.07 # 5082-87-3HP, CUFF BLOOD PRESSURE LG ADULT, 22 Del Qty, $1,747.02 # 5082-84-3HP, CUFF BLOOD PRESSURE CHILD, 20 Del Qty, $1,446.40 # 5090-02, ANEROID POCKET ADULT CUFF, 12 Del Qty, $1,243.80 #DS45-11C, CUFF BLOOD PRESSURE ADLT 1 PC WITH CASE, 17 Del Qty, $839.29 #5090-41, ANEROID POCKET LRG ADULT CUFF, 8 Del Qty, $829.20 # BP251020, CUFF BLOOD PRESSURE NEONATE #4 1 TUBE, 11 Del Qty, $801.90 #002791, CUFF BP DURA-CUF BLADDERLESS LARGE, 35 Del Qty, $780.45 At the request of the Pacific Regional MTFs, vendors will provide conversion information, prime vendor order numbers, and itemization of the brands, types, and packaging information of the products supplied by the vendor. C. Instructions to Vendors DAPA holders interested in participating in this standardization initiative should email their (1) Company name and address, (2) Point of Contact (POC) (Name and Phone Number, Fax Number, and E-mail address) to mary.summers1@us.army.mil AND cheryl.janus@amedd.army.mil. Submissions must be received by 5:00 post meridiem (p.m.) Hawaii Standard Time (HST) on the specified closing date/time of this solicitation. Vendors that fail to meet this submittal deadline will be disqualified from participating. All e-mail communications between vendors and the region will be digitally signed. This process will include vendor requirements to provide electronic responses to technical criteria, no charge product samples and literature for clinical evaluation, and submission of electronic best price quotes. Due to the potential for email to be lost in transmission from network security, etc., vendors are strongly encouraged to confirm with the Regional POC stated above that their initial submission, quotes, and literature or other requested information has actually arrived at the Regional TRBO via email. Each submitting vendor is advised to confirm receipt, allowing adequate time for resubmission before the due date/time, should a problem occur with the first submission. The region reserves the right to cancel, repost, or reissue the FBO; if industry response is low. D. Source Selection Procedures The Tri-Service Product Review Board (TPRB) is the governing body of the standardization process and program. This board includes clinicians and logisticians from the MTFs within the Pacific Region. The board is chaired by the Designated Senior Logistician (DSL) and Co-Chaired by a physician and nurse from the Naval Hospital Yokosuka and the Hawaii Multi Service Marketing Management Office, respectively. They are the deciding officials for this initiative. The Region intends to evaluate quotes and select a vendor or vendor(s), without discussions. Vendor quotes should contain the vendor's best product matches for the products or product lines requested in this announcement. Vendor quotes should contain the vendor's best responses to all technical and/or company questions listed in this announcement. Vendor quotes should contain the vendor's best tiered-pricing discounts off of the vendor's DAPA pricing (based on committed volume of 80% of the total requirements of the MTFs in the Pacific Region). Additionally, the Region reserves the right to conduct discussions and request revised quotes, if it is determined to be necessary. If industry participation is unsatisfactory, the TPRB will decide whether to proceed with or delay the project. Interested vendors are to respond to this Federal Business Opportunity (FBO) announcement by emailing their intent to participate to the above POC by the required response date. This source selection procedure is a one-step process. The TRBO will request responses to the technical/company criteria, the no charge literature and no charge sample set, and best value pricing from the vendor in a one-step source selection process. Vendors will have 30 calendar days to respond to the TRBO with their responses to the technical/company criteria, delivery of the no charge literature and no charge sample set to the participating MTFs, and submission of best value price quotes. Vendors technical criteria response will be in a prescribed electronic spreadsheet format. Best value pricing will be in a prescribed electronic spreadsheet format, based upon the total requirements of the Pacific Region. Vendors that fail to respond to the technical/company criteria or fail to send the no charge literature and no charge sample set or fails to provide a best value price quote will be disqualified from further consideration in the standardization initiative. No charge literature and no charge samples must be received by the participating MTFs by close of business (COB) 5:00 PM HST, 30 days after the date of request to supply samples. All vendors must send the TRBO verification regarding the date of shipment. All communications of significant acquisition milestones (such as invitations to participate, or notices of disqualification) must be digitally signed. Vendors that have been disqualified will be notified in writing by e-mail at the conclusion of the process. Acceptability for purposes of evaluation of technical/company criteria is defined as follows: 1) based on the vendors responses, the evaluators have reasonable confidence the line of products and/or services submitted meet the medical standards of care of the community, applicable to such products or services, 2) the vendors information provided is factually correct. Any misrepresentation of information will disqualify the vendor from further consideration. Specific technical/company criteria will require an additional more specific definition of technical acceptability. The specific standard for technical acceptability will be set forth with the individual statement of each criterion, as required. The no charge samples to be provided are as follows: One (1) each of the following Blood Pressure Cuffs, Reusable types: 1) Infant Blood Pressure Cuff and One-Tube Bladder; 2) Child Blood Pressure Cuff and One-Tube Bladder; 3) Adult Blood Pressure Cuff and One-Tube Bladder; 4) Infant Blood Pressure Cuff and Two-Tube Bladder; 5) Child Blood Pressure Cuff and Two-Tube Bladder; 6) Adult Blood Pressure Cuff and Two Tube Bladder. The designated MTFs that will be participating in the clinical evaluation are: Tripler Army Medical Center, U.S. Naval Hospital Okinawa, U.S. Naval Hospital Guam, U.S. Naval Hospital Yokosuka, and U.S. Army Health Clinic Schofield Barracks, and Naval Health Clinic Hawaii. The no charge literature and no charge sample sets are required to be shipped to the following MTFs: Tripler Army Medical Center ATTN: George Fitzgerald, TPRB Standardization Committee Logistics Division, Materiel Branch Bldg 161 Krukowski Road Honolulu, Hawaii 96859-5000 (808) 433-1711/ 1737 US Naval Hospital Guam Farenholt Road Bldg 1, Room L103 Attn: Supply Officer Agana Heights, Guam 96910 671-344-9671 U.S. Naval Hospital, Yokosuka, Japan 1-Chome, Honcho, Yokosuka, Kanagawa 238-0041 Attn: Rockie Ramirez, Warehouse BLDG E-18 Phone: 011-81-46-816-8592/7130 Mark for: PO N68292 US Naval Hospital Okinawa Japan TPRB Evaluation Samples Attn: Supply Chief Bldg 6000, Camp Lester Chatan-Cho, Nakagami-Gun, Okinawa, Japan 904-0103 011-81-611-743-7815 U.S. Army Health Clinic Attn: CPT Owen Roberts, MCHK-HC-MS Logistics Section, Bldg. 679 Schofield Barracks, HI 96857-5460 808-433-8490 Naval Health Clinic Hawaii, Code 02 Attn: Mr. Raoul Allen 480 Central Avenue Pearl Harbor, HI 96860-4908 808-471-2594 Specific Clinical Product Teams (CPTs), at the designated MTFs, will evaluate the clinical/performance criteria using a likert type scale, with a one to five rating. One (1) = Strongly Disagree; Two (2) = Disagree; Three (3) = Neutral; Four (4) = Agree; Five (5) = Strongly Agree. The evaluating CPTs, which consist of physicians, nurses, allied health professionals, and technicians from the participating MTFs will evaluate the products based on the evaluation criteria below. The TPRB CPT intends that clinical evaluations be conducted in a non-clinical (non-patient) setting. The Region intends to evaluate quotes and select a vendor or vendor(s), on initial submission/quotes. Vendor quotes should contain the vendor's best product matches for the products or product lines requested in the announcement. Vendor quotes should contain the vendor's best tiered-pricing discounts off the Vendor's DAPA pricing (based on committed volume of 80% of the total requirements of the MTFs in the Pacific Region). Pricing will be based on a committed volume for a two-year period with possible one-year option periods not to exceed a total of 5 years. However, the Region reserves the right to request revised quotes, if determined necessary. The Region reserves the right to limit the number of quotes to the greatest number that will permit an efficient competition among vendors. Vendors that fail to submit price quotes will be disqualified from further consideration in this standardization initiative. Technical/Company and Clinical/Performance factors will be weighted more heavily than price. As the technical and clinical evaluation results become more equal, price will become more important. Pricing will be evaluated based on best value to the government and will be based on a committed volume for a 2-year period with possible one-year option periods (not to exceed 5 years). The following elements will be considered in the pricing analysis: (1) Impact of RIA prices on the Region (Post-Standardization Costs), (2) Impact of Unmatched Lines, (3) Potential Cost Avoidance (this is included as a reporting metric) and (4) consideration of stockage keeping units (SKUs) by each vendor. SKU review will assess the number of line items a vendor is able to supply to the MTFs versus the number of currently used line items. Cost avoidance is used as a reporting metric, not as an element of the decision. Technical/Company Criteria 1.Vendors must manufacture and/or distribute a complete product line of Blood Pressure Cuffs, Reusable. A complete line of product is defined as the MTFs requirements for usage items in the product line. Usage items are defined in the Medical Surgical Prime Vendor contract statement of work as DAPA items ordered at least once per month, and at least one unit per order. At a minimum, a complete product line includes the following products in the following sizes: 1) Infant Blood Pressure Cuff and One-Tube Bladder; 2) Child Blood Pressure Cuff and One-Tube Bladder; 3) Adult Blood Pressure Cuff and One-Tube Bladder; 4) Infant Blood Pressure Cuff and Two-Tube Bladder; 5) Child Blood Pressure Cuff and Two-Tube Bladder; 6) Adult Blood Pressure Cuff and Two-Tube Bladder. 2.Vendors must have a DAPA or be in the process of applying for a DAPA number for Blood Pressure Cuffs, Reusable. Provide the DAPA number or proof of the application process with the initial submittal. Vendors that fail to have a DAPA or show a lack of progress in obtaining a DAPA will be disqualified. 3.Vendors must have a separate agreement with the prime vendor Cardinal Health for distribution in this Region and provide certification of this with the initial submittal. Vendors whose products are not available through the regional PV will be disqualified. 4.Vendors must provide discounts off DAPA for all products included in this standardization initiative. Where lower FSS prices are available, DAPA holders are required by previous agreement to provide the FSS price as their DAPA price. Therefore, FSS prices do not represent a discount off DAPA. Vendors that fail to provide a discount from DAPA will be disqualified. 5.Vendor must provide latex free blood pressure cuffs, reusable. 6.Vendors must provide replacement latex free bladders. 7.Vendors must provide blood pressure cuffs, which are made of either nylon, rayon, a combination of nylon and rayon or PVC or Neoprene. 8.Vendors will provide the following connectors: 1) female luer, bayonet, screw connector, and male slip connector for the one-tail blood pressure cuffs; 2) female luer, bayonet, screw connector, and male slip connector for the two tail blood pressure cuffs. These may be individual connectors or a combination of functions as in a 4 in 1 or a 5 in 1 connector Clinical/Performance Criteria 1.Inside of cuff is smooth, with no sharp edges, no areas of uneven distribution of material, any puckering, or bunching of seams and edges. (Inside of cuff is smooth, evenly woven materials, avoiding clumping, creasing or bunching of layers, which would put unequal compression on the patients skin) Addresses patient safety. a.The inside of the blood pressure cuff is smooth, without any areas of roughness or uneven assembly. b.This criterion will be evaluated one time by the clinician performing a visual inspection of the cuff. c.The evaluators will carefully examine the inside surface of the cuff, both visually and with tactile examination. The expectation is that the inside of the cuff will be free of any rough edges, creasing or puckering of materials, which could cause uneven compression and pain to the patient. 2.Products Velcro closure is firm and adheres throughout the taking of the blood pressure. (Uneven adherence of Velcro closure will compromise the accuracy of the inflation and deflation process) Addresses patient safety and accuracy of diagnostic monitoring. a.The blood pressure cuff will maintain the correct position, inflate, and deflate evenly via the firm and adherent grasp of the Velcro closure. b.This criterion will be evaluated by the clinician applying the cuff and taking a blood pressure one time in a clinical setting. c.The expectation is that the Velcro closure will adhere firmly and evenly. 3.The entire blood pressure cuff will inflate and deflate evenly. (No areas of non-inflation or non-deflation will be discovered) Addresses patient safety and accuracy of diagnostic monitoring. a.The cuff will clearly inflate and deflate in an even fashion air will inflate the cuff in a circumferential manner and deflate in the reverse circumferential manner. b.This criterion will be evaluated by the clinician applying the cuff and taking a blood pressure in a clinical setting. c.The expectation is that the cuff will evenly and in a circumferential manner inflate and deflate, eliminating the possibility that the cuffs manometer reading will be inaccurate; thereby, loosing the therapeutic and diagnostic purpose of the product.
Web Link: FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=7651f3a303924fbb205c06abdd093b1f&tab=core&_cview=1)
Place of Performance: Address: Pacific Regional Contr Ofc TAMC ATTN: MCAA PC BLDG 160, 160 Krukowski Road Honolulu HI<br />; Zip Code: 96859-5000<br />
Record: SN01665368-W 20080912/080910220622-7651f3a303924fbb205c06abdd093b1f (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |

Loren Data's SAM Daily™

65 -- The Pacific Region-Tri Service Regional Business Office, comprised of 17 Medical Treatment Facilities announces a Request for Regional Incentive Agreement Quotation (RFRIAQ) for the standardization of Blood Pressure Cuffs, Reusable.